COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the return of raised funds

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-021

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement on the return of raised funds

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

 

Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”) reviewed and approved the “Thirty-eighth Meeting of the 4th Board of Directors” held on November 18, 2012, regarding the temporary replenishment of working capital by using part of the idle raised funds. The Bill agrees that the company will use the 50 million yuan idle raised funds to temporarily replenish the working capital, and the period of use will not exceed six months, from November 19, 2012 to May 18, 2013. For details of the use of some of the idle raised funds to temporarily supplement the working capital, please refer to the “Securities Times”, “China Securities Journal”, “Shanghai Securities News”, “Securities Daily” and www.cninfo.com.cn on November 20, 2012. .cninfo.com.cn) Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the temporary replenishment of working capital using some idle raised funds (2012-045).

 

On May 17, 2013, the company returned all of the above-mentioned funds raised from the temporary replenishment of working capital of 50 million yuan to the fundraising account, and the use period was less than 6 months. The company has notified the sponsor institution Northeast Securities Co., Ltd. and the sponsor representative of the return of the above raised funds.

 

Special announcement

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

May 18, 2013